MBI-853NL

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMBI-853NL
Drug Alias NameMBI-853NL
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMigenix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMigenix
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A